ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 24 filers reported holding ALBIREO PHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $12,359,000 | -56.9% | 486,181 | -66.1% | 0.18% | -14.2% |
| Q3 2019 | $28,656,000 | +24.1% | 1,432,762 | +100.0% | 0.21% | -39.1% |
| Q2 2019 | $23,096,000 | +0.1% | 716,381 | 0.0% | 0.35% | -23.3% |
| Q1 2019 | $23,075,000 | +31.3% | 716,381 | 0.0% | 0.45% | +59.9% |
| Q4 2018 | $17,573,000 | -25.6% | 716,381 | 0.0% | 0.28% | -5.3% |
| Q3 2018 | $23,612,000 | -7.2% | 716,381 | 0.0% | 0.30% | -9.9% |
| Q2 2018 | $25,432,000 | +0.5% | 716,381 | -7.8% | 0.33% | -12.8% |
| Q1 2018 | $25,310,000 | +27.2% | 777,096 | 0.0% | 0.38% | +25.2% |
| Q4 2017 | $19,894,000 | +22.2% | 777,096 | 0.0% | 0.30% | +16.0% |
| Q3 2017 | $16,280,000 | +1.7% | 777,096 | 0.0% | 0.26% | +20.6% |
| Q2 2017 | $16,008,000 | -14.2% | 777,096 | 0.0% | 0.22% | -3.1% |
| Q1 2017 | $18,650,000 | +35.4% | 777,096 | 0.0% | 0.22% | +51.0% |
| Q4 2016 | $13,778,000 | – | 777,096 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 198,800 | $5,266,000 | 2.26% |
| Perceptive Advisors | 1,960,139 | $51,924,000 | 0.84% |
| Chicago Capital, LLC | 502,212 | $13,304,000 | 0.77% |
| Birchview Capital, LP | 48,000 | $1,272,000 | 0.77% |
| Artal Group S.A. | 500,360 | $13,255,000 | 0.37% |
| HEARTLAND ADVISORS INC | 150,000 | $3,974,000 | 0.35% |
| Eversept Partners, LP | 78,029 | $2,066,988 | 0.28% |
| ArrowMark Colorado Holdings LLC | 956,990 | $25,351,000 | 0.26% |
| PA Capital LLC | 12,987 | $344,000 | 0.25% |
| Ikarian Capital, LLC | 100,500 | $2,662,000 | 0.21% |